Side-by-side comparison of AI visibility scores, market position, and capabilities
Dublin physical security and access control (NYSE: ALLE) at $3.8B 2024 revenue; Q2 2025 record $1B+ quarterly with Salto Systems and Gatewise acquisitions expanding electronic access competing with ASSA ABLOY for global door security.
Allegion plc is a Dublin, Ireland-headquartered global security products company — publicly traded on the New York Stock Exchange (NYSE: ALLE) as an S&P 500 component — generating $3.8 billion in revenue in 2024 and setting a quarterly revenue record exceeding $1 billion in Q2 2025 for the first time in company history, with approximately 14,400 employees across operations in 130+ countries. Allegion's portfolio spans 25+ brands including Schlage (US residential and commercial locks), Von Duprin (exit devices since 1908), LCN (door closers since 1876), CISA (European locks), SimonsVoss (wireless electronic locking), and Interflex (workforce management). The company generates 75%+ of sales in the United States. CEO John H. Stone. Allegion was spun off from Ingersoll Rand on December 1, 2013, joining the NYSE and S&P 500 on the same day. Recent acquisitions include Salto Systems (2024, cloud-connected access control), Gatewise (2025, multifamily access control), and ELATEC (2025 pending, RFID/NFC reader technology).
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.